Lutetium-177 Dotatate Peptide Receptor Radionuclide Therapy in metastatic pheochromocytoma and paraganglioma: Experience in our center

#4250

Introduction: -

Aim(s): The aim was to assess the usefulness of Lutetium-177dotatate in patients diagnosed with metastatic pheochromocytoma (Pheo) or paraganglioma (PGL).

Materials and methods: A retrospective-analysis of patients diagnosed with metastatic-Pheo/PGL and referred to treatment with Lutetium-177dotatate after demonstration of somatostatin receptors expression was performed.

Conference:

Presenting Author: Negre M

Authors: Negre M, Guardeño R, Biarnés J, Recasens M, Rubió A,

Keywords: PRRT, 177Lu-Dotatate, Metastastatic Paraganglioma, Metastatic Pheocromocytoma,